Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)

BALA CYNWYD, Pa., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Paya Holdings Inc. (Nasdaq – PAYA)

Under the terms of the agreement, Paya will be acquired by Nuvei Corporation (Nasdaq - NVEI) (“Nuvei”). Paya stockholders will receive $9.75 per share in an all-cash transaction valued at approximately $1.3 billion. The investigation concerns whether the Paya Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Nuvei is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/paya-holdings-inc-nasdaq-paya/.

CinCor Pharma, Inc. (Nasdaq – CINC)

Under the terms of the agreement, CinCor will be acquired by AstraZeneca PLC (“AstraZeneca”) (Nasdaq – AZN). CinCor stockholders will receive $26.00 per share at closing plus a non-tradable contingent value right of $10.00 per share in cash payable upon a specified regulatory submission of a baxdrostat product. The investigation concerns whether the CinCor Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether AstraZeneca is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cincor-pharma-inc-nasdaq-cinc/.

Albireo (Nasdaq – ALBO)

Under the terms of the agreement, Albireo will be acquired by Ipsen for $42.00 per share in cash at the closing of the transaction, for an initial estimated aggregate consideration of $952 million plus one contingent value right (CVR) per share. Each CVR will entitle its holder to deferred cash payments of $10.00 per CVR payable upon the U.S. Food and Drug Administration (FDA) approval of Bylvay in the Biliary Atresia indication at the latest by 31 December 2027, allowing for a potential increase in the number of patients in the BOLD study. The investigation concerns whether the Albireo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Ipsen is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/albireo-nasdaq-albo/.

Duck Creek Technologies (Nasdaq - DCT)

Under the terms of the agreement, Duck Creek will be acquired by Vista Equity Partners (“Vista”). Duck Creek stockholders will receive $19.00 per share in an all-cash transaction valued at approximately $2.6 billion. The investigation concerns whether the Duck Creek Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Vista is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/duck-creek-technologies-nasdaq-dct/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.